Pages

• About VASCERN
  • ERNs
• Contact
• EU languages
  • Accordéons
  • Dansk
  • Deutsch
  • Español
  • Français
  • Italiano
  • Magyar
  • Nederlands
  • Svenska
• EU languages
  • Čeština
  • Eesti
  • Français
  • Hrvatski
  • Latviešu
  • Lietuvių
  • Maltese
  • Norwegian
  • Polski
  • Português
  • Română
  • Slovenčina
  • Slovenščina
  • Suomi
  • ελληνικά
  • български / bɤɫɡɐrski
• Expertise
  • ePAG (Patient Advocacy)
  • Rare Diseases WGs
    • Hereditary Haemorrhagic Telangiectasia (HHT-WG)
    • Heritable Thoracic Aortic Diseases (HTAD-WG)
    • Medium Sized Arteries (MSA-WG)
    • Neurovascular Diseases (NEUROVASC)
    • Other Rare Diseases to be included
    • Pediatric and Primary Lymphedema (PPL-WG)
    • Vascular Anomalies (VASCA-WG)
  • Transversal WGs
    • Communication WG
    • Ethics WG
    • Pregnancy WG
    • Registry WG
• HOME
  • EU calls
  • Event list for newsletters
  • Formulaire test
  • Legal Disclaimer
  • Sitemap
  • Upcoming events
  • VASCERN’s COVID19 recommendations
• News
  • Events & EU Calls
  • Newsletter
  • Newsletters
  • Research News
  • VASCERN Spotlights
• No Access
• Not online
  • Calls for clinical trials
  • Non-Heritable Vascular Diseases WG
  • Reports
• TestMP4
• Training and Education
• What we do
  • Clinical Expert Consensus Statements Written (Clinical Decision Support Tools)
  • Clinical Outcomes Measures
  • Clinical Practice Guidelines (CPGs) selected
  • Clinical Trials & Research Studies
  • CPMS: discussion of complex clinical cases
  • Do’s & Don’ts Factsheets (Clinical Decision Support Tools)
  • Exchange Program
  • Mobile App
  • Patient Pathways (Clinical Decision Support Tools)
  • Registry
  • Webinars and Pills of Knowledge (Educational videos)